Ploumen, Roxanne A. W. http://orcid.org/0000-0003-1024-3519
Claassens, Eva L.
Kooreman, Loes F. S.
Keymeulen, Kristien B. M. I.
van Kats, Maartje A. C. E.
Gommers, Suzanne
Siesling, Sabine
van Nijnatten, Thiemo J. A.
Smidt, Marjolein L.
Funding for this research was provided by:
Jules Coenegracht Sr Foundation
Article History
Received: 29 March 2023
Accepted: 12 June 2023
First Online: 3 July 2023
Declarations
:
: The authors declare the following financial interests/personal relationships: Prof. Dr. Smidt reports grants from Nutricia and Servier Pharmaceuticals for microbiome research in colorectal cancer, not related to this study. Dr. T. van Nijnatten received institutional grant support from Bayer, and speaker honoraria from GE Healthcare and Bayer, not related to this study. L. Kooreman reports consulting fees from Novartis and educational fees from SCEM, not related to this study. All other authors declare no conflicts of interest.
: The current study was approved by the institutional ethics and privacy committee of The Netherlands Comprehensive Cancer Organization (IKNL) after reviewing the study protocol.